INTERNATIONAL PATENT: IVIEW THERAPEUTICS, INC. FILES APPLICATION FOR "NOVEL EYELID DELIVERY OF OPHTHALMIC COMPOSITION CONTAINING MUSCARINIC RECEPTOR MODULATORS FOR PREVENTION AND TREATMENT OF OCULAR DISORDERS"

GENEVA, March 25 -- IVIEW THERAPEUTICS, INC. (5 Cedar Brook DriveSuite 2Cranbury, New Jersey 08512) filed a patent application (PCT/US2025/046579) for "NOVEL EYELID DELIVERY OF OPHTHALMIC COMPOSITION CONTAINING MUSCARINIC RECEPTOR MODULATORS FOR PREVENTION AND TREATMENT OF OCULAR DISORDERS" on Sep 16, 2025. With publication no. WO/2026/060434, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIANG, Bo (4 Marchall Ct.Plainsboro, New Jersey 08536), WANG, Wei (4 Marchall Ct.Plainsboro, New Jersey 08536), YAO, Zuliang (51 Ayli...